Ofloxacin (oral)

Ofloxacin (oral)

File:Ofloxacin.svg
Clinical data
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	Topical (ear drops)
ATC code	J01MA01 (WHO) J01MA02 (WHO), J01MA12 (WHO), S01AX11 (WHO), S01AX13 (WHO), S01AX19 (WHO), S03AA07 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Protein binding	32%
Elimination half-life	9 hours
Identifiers
IUPAC name (+/-)-9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)- 7-oxo-7H-pyrido [1,2,3-de]-1, 4-benzoxazine-6-carboxylic acid
CAS Number	82419-36-1
PubChem CID	4583
DrugBank	APRD00502
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C18H20FN3O4
Molar mass	361.368 g/mol

WikiDoc Resources for Ofloxacin (oral)
Articles
Most recent articles on Ofloxacin (oral) Most cited articles on Ofloxacin (oral) Review articles on Ofloxacin (oral) Articles on Ofloxacin (oral) in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ofloxacin (oral) Images of Ofloxacin (oral) Photos of Ofloxacin (oral) Podcasts & MP3s on Ofloxacin (oral) Videos on Ofloxacin (oral)
Evidence Based Medicine
Cochrane Collaboration on Ofloxacin (oral) Bandolier on Ofloxacin (oral) TRIP on Ofloxacin (oral)
Clinical Trials
Ongoing Trials on Ofloxacin (oral) at Clinical Trials.gov Trial results on Ofloxacin (oral) Clinical Trials on Ofloxacin (oral) at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ofloxacin (oral) NICE Guidance on Ofloxacin (oral) NHS PRODIGY Guidance FDA on Ofloxacin (oral) CDC on Ofloxacin (oral)
Books
Books on Ofloxacin (oral)
News
Ofloxacin (oral) in the news Be alerted to news on Ofloxacin (oral) News trends on Ofloxacin (oral)
Commentary
Blogs on Ofloxacin (oral)
Definitions
Definitions of Ofloxacin (oral)
Patient Resources / Community
Patient resources on Ofloxacin (oral) Discussion groups on Ofloxacin (oral) Patient Handouts on Ofloxacin (oral) Directions to Hospitals Treating Ofloxacin (oral) Risk calculators and risk factors for Ofloxacin (oral)
Healthcare Provider Resources
Symptoms of Ofloxacin (oral) Causes & Risk Factors for Ofloxacin (oral) Diagnostic studies for Ofloxacin (oral) Treatment of Ofloxacin (oral)
Continuing Medical Education (CME)
CME Programs on Ofloxacin (oral)
International
Ofloxacin (oral) en Espanol Ofloxacin (oral) en Francais
Business
Ofloxacin (oral) in the Marketplace Patents on Ofloxacin (oral)
Experimental / Informatics
List of terms related to Ofloxacin (oral)

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Ofloxacin (sold under the brand name Floxin® in the United States, Tarivid® in Europe and some other countries) is a fluoroquinolone antibiotic. Ofloxacin is the racemic mixture of the chiral compound. The biologically active enantiomer is sold separately under the name of levofloxacin. It is used as a treatment for gonorrhoea and is an alternative treatment to ciprofloxacin for anthrax.

External links

• Ofloxacin: an overview - A site with its chemical properties and alternate brand names.